Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s share price passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $10.18 and traded as low as $7.4701. Ampliphi Biosciences shares last traded at $8.12, with a volume of 67,386 shares.
Ampliphi Biosciences Price Performance
The business’s fifty day moving average is $10.11 and its 200-day moving average is $8.17.
About Ampliphi Biosciences
Ampliphi Biosciences, Inc is a clinical‐stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the discovery and development of novel therapies to prevent and treat life‐threatening drug‐resistant infections. The company’s core mission is to address the growing global threat of antibiotic resistance by advancing first‐in‐class and best‐in‐class antibacterial agents through late‐stage clinical trials.
The company’s lead product candidate, exeporfinium chloride (XF-73), is a pioneering topical antibacterial designed for pre‐operative nasal decolonization of Staphylococcus aureus in patients undergoing high‐risk surgical procedures.
Featured Stories
- Five stocks we like better than Ampliphi Biosciences
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
